91ÊÓƵ

President Donald Trump’s new tariffs on pharmaceutical imports will not apply to countries with negotiated agreements with the U.S. that contain provisions on drugs.

The move cements the terms of the framework trade agreement the two sides struck this summer.

EU trade chief Maros Sefcovic will meet with U.S. Trade Representative Jamieson Greer on the sidelines of the ASEAN ministerial summit in Kuala Lumpur.

Members of the European Parliament are pushing to insert a sunset clause that would limit the duration of tariff cuts on American industrial goods, and to adjust duties on specific products.

If the EU proposes the legislation by the end of the month, then the 15% tariff rate on European cars will be back-dated to Aug. 1.

The joint statement advances the preliminary deal announced a month ago, by including specific benchmarks for the EU to secure tariff discounts on cars, pharmaceuticals and semiconductors.

Frustration and economic losses like those in the U.K. are growing in Japan, the European Union and South Korea.

Under the terms agreed with Washington, the 27-nation bloc faces a 15% U.S. tariff on most of its exports. That rate would also apply to cars rather than the current 25% level.

Key details remain sparse — or not immediately captured in writing. Here’s what we know about the agreements so far.

The U.S. and the EU agreed to a trade framework setting a 15% tariff on most goods, staving off — at least for now — far higher import duties that might have sent shock waves around the globe.